2,686 Shares in UnitedHealth Group Incorporated (NYSE:UNH) Bought by Nabity Jensen Investment Management Inc

Nabity Jensen Investment Management Inc acquired a new position in UnitedHealth Group Incorporated (NYSE:UNH) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 2,686 shares of the healthcare conglomerate’s stock, valued at approximately $1,570,000. UnitedHealth Group comprises 1.2% of Nabity Jensen Investment Management Inc’s investment portfolio, making the stock its 19th biggest holding.

Several other hedge funds and other institutional investors also recently bought and sold shares of UNH. International Assets Investment Management LLC boosted its stake in shares of UnitedHealth Group by 78,814.4% in the third quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock worth $3,096,896,000 after buying an additional 5,290,025 shares during the last quarter. Lone Pine Capital LLC purchased a new stake in UnitedHealth Group in the 2nd quarter worth approximately $480,903,000. Dimensional Fund Advisors LP increased its holdings in shares of UnitedHealth Group by 30.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock valued at $1,942,956,000 after purchasing an additional 880,183 shares in the last quarter. Baillie Gifford & Co. boosted its holdings in UnitedHealth Group by 1,125.4% during the second quarter. Baillie Gifford & Co. now owns 894,006 shares of the healthcare conglomerate’s stock worth $455,281,000 after buying an additional 821,050 shares in the last quarter. Finally, Accredited Investors Inc. increased its holdings in UnitedHealth Group by 9,235.4% in the third quarter. Accredited Investors Inc. now owns 784,924 shares of the healthcare conglomerate’s stock valued at $458,929,000 after buying an additional 776,516 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently commented on UNH shares. Oppenheimer raised their target price on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research report on Friday. Morgan Stanley dropped their price target on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 16th. Royal Bank of Canada decreased their price objective on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a report on Wednesday, October 16th. Barclays boosted their price objective on UnitedHealth Group from $603.00 to $655.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 27th. Finally, TD Cowen boosted their price target on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research report on Friday, October 18th. Four investment analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $626.84.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock opened at $549.62 on Monday. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The business has a 50-day simple moving average of $586.84 and a 200-day simple moving average of $559.07. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. The company has a market cap of $505.80 billion, a PE ratio of 35.81, a P/E/G ratio of 1.61 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. During the same period last year, the firm earned $6.56 earnings per share. UnitedHealth Group’s quarterly revenue was up 9.2% on a year-over-year basis. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 27.63 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be issued a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.53%. The ex-dividend date of this dividend is Monday, December 9th. UnitedHealth Group’s payout ratio is 54.72%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.